Copyright
©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. Nov 6, 2016; 7(4): 556-563
Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.556
Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.556
Table 2 Prevalence and odds ratio of having family history of inflammatory bowel disease in China vs the United States
China(n = 49) | United States(n = 145) | Unadjusted OR (95%CI) P value (Reference = US) | Adjusted1 OR (95% CI) P value (Reference = US) | |
Any family history of IBD (%) | 4.1% (n = 2) | 39.3% | 0.07 (0.02-0.28) | 0.08 (0.02-0.34) |
P = 0.0002 | P = 0.0008 | |||
First-degree family history of IBD (%) | 4.1% (n = 2) | 23.5% | 0.14 (0.03-0.60) | 0.14 (0.03-0.65) |
P = 0.008 | P = 0.01 |
- Citation: Wang PQ, Hu J, Al Kazzi ES, Akhuemonkhan E, Zhi M, Gao X, de Paula Pessoa RH, Ghazaleh S, Cornelius T, Sabunwala SA, Ghadermarzi S, Tripathi K, Lazarev M, Hu PJ, Hutfless S. Family history and disease outcomes in patients with Crohn’s disease: A comparison between China and the United States. World J Gastrointest Pharmacol Ther 2016; 7(4): 556-563
- URL: https://www.wjgnet.com/2150-5349/full/v7/i4/556.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v7.i4.556